Charles River Will Buy WuXi PharmTech

Charles River Laboratories has agreed to buy WuXi PharmTech, in a deal that Bloomberg News calls the "largest foreign takeover of a Chinese company" to date. The move eliminates a potential competitor for Charles River and gives it an instant major presence in the Chinese contract research and manufacturing market. For the full story, click here.

More News:

All news »

What are your comments?

Join the discussion today. Login Here.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments